Skip to main content
. Author manuscript; available in PMC: 2020 Jul 28.
Published in final edited form as: Ann Surg. 2018 Mar;267(3):544–551. doi: 10.1097/SLA.0000000000002069

TABLE 1.

Demographic and Clinical Characteristics Among All Patients Stratified By Receipt of Adjuvant Therapy

No Adjuvant Therapy (n = 1075) Adjuvant Therapy (n = 1333) Total (n = 2408)
Sex
 Male 506 (47.1) 724 (54.3) 1230 (51.1)
 Female 569 (52.9) 609 (45.7) 1178 (48.9)
Age group, y
 18–34 68 (6.3) 9 (0.7) 77 (3.2)
 35–44 106 (9.9) 82 (6.2) 188 (7.8)
 45–54 274 (25.5) 349 (26.2) 623 (25.9)
 55–64 627 (58.3) 893 (67.0) 1520 (63.1)
Charlson Co-morbidity Index
 ≤2 568 (52.8) 508 (38.1) 1076 (44.7)
 >2 507 (47.2) 825 (61.9) 1332 (55.3)
 Procedure type
 Proximal pancreatectomy 15 (1.4) 13 (1.0) 28 (1.2)
 Distal pancreatectomy 418 (38.9) 229 (17.2) 647 (26.9)
 Radical antegrade pancreaticosplenectomy 14 (1.3) 12 (0.9) 26 (1.1)
 Other partial pancreatectomy 60 (5.6) 22 (1.7) 82 (3.4)
 Total pancreatectomy 42 (3.9) 58 (4.4) 100 (4.2)
 Whipple 526 (48.9) 999 (74.9) 1525 (63.3)
Complications hospitalization
 0 783 (72.8) 1017 (76.3) 1800 (74.8)
 1 266 (24.7) 293 (22.0) 559 (23.2)
 2 or more 26 (2.4) 23 (1.7) 49 (2.0)
Nodal involvement
 No 838 (78.0) 754 (56.6) 1592 (66.1)
 Yes 237 (22.0) 579 (43.4) 816 (33.9)
Neoadjuvant therapy
 No 942 (87.6) 1051 (78.8) 1993 (82.8)
 Yes 133 (12.4) 282 (21.2) 415 (17.2)